Eiken Chemical Co., Ltd. (TYO:4549)
2,449.00
+15.00 (0.62%)
Sep 17, 2025, 3:30 PM JST
Eiken Chemical Revenue
Eiken Chemical had revenue of 10.20B JPY in the quarter ending June 30, 2025, with 7.12% growth. This brings the company's revenue in the last twelve months to 41.22B, up 3.80% year-over-year. In the fiscal year ending March 31, 2025, Eiken Chemical had annual revenue of 40.54B with 1.22% growth.
Revenue (ttm)
41.22B
Revenue Growth
+3.80%
P/S Ratio
1.95
Revenue / Employee
58.71M
Employees
702
Market Cap
80.20B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 40.54B | 487.00M | 1.22% |
Mar 31, 2024 | 40.05B | -3.22B | -7.44% |
Mar 31, 2023 | 43.27B | 275.00M | 0.64% |
Mar 31, 2022 | 43.00B | 4.33B | 11.20% |
Mar 31, 2021 | 38.67B | 2.08B | 5.69% |
Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Chugai Pharmaceutical | 1,196.21B |
HOYA Corporation | 876.09B |
Takeda Pharmaceutical Company | 4,480.25B |
Daiichi Sankyo Company | 1,924.68B |
Otsuka Holdings | 2,401.70B |
Terumo | 1,037.94B |
Astellas Pharma | 1,944.99B |
Shionogi & | 440.50B |